Carrie M Mintz
Overview
Explore the profile of Carrie M Mintz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu K, Berkel T, Martin C, Jones H, Carter E, Kelly J, et al.
Nat Ment Health
. 2024 Dec;
2(7):801-808.
PMID: 39726823
While attention deficit hyperactivity disorder is common among people with addiction, the risks and benefits of attention deficit hyperactivity disorder medication in pregnant people with opioid use disorder are poorly...
2.
Mintz C, Knox J, Hartz S, Hasin D, Martins S, Kranzler H, et al.
Alcohol Clin Exp Res (Hoboken)
. 2023 Oct;
47(10):1890-1903.
PMID: 37864538
Background: The screening, brief intervention, and referral to treatment (SBIRT) model is recommended by the U.S. Preventive Services Task Force to improve recognition of and intervention for unhealthy alcohol use....
3.
De Monnin K, Terian E, Yeary J, Bathon E, Asaro P, Mintz C, et al.
Acad Emerg Med
. 2023 Oct;
31(5):525-528.
PMID: 37822078
No abstract available.
4.
Hartz S, Culverhouse R, Mintz C, Ellis M, Kasper Z, Cavazos-Rehg P, et al.
PLoS One
. 2022 Nov;
17(11):e0271379.
PMID: 36441691
Chronic pain increases risk for opioid overdose among individuals with opioid use disorder. The purpose of this study is to evaluate the relationship between recent overdose and whether or not...
5.
Xu K, Mintz C, Presnall N, Bierut L, Grucza R
J Clin Psychiatry
. 2022 Jun;
83(4).
PMID: 35759785
Stimulant use has substantially increased among people with opioid use disorder (OUD) and is associated with worse treatment outcomes. This study's objective was to compare risk of stimulant-related emergency department...
6.
Mintz C, Xu K, Presnall N, Hartz S, Levin F, Scherrer J, et al.
JAMA Netw Open
. 2022 May;
5(5):e2211634.
PMID: 35544135
Importance: Stimulant medication use is common among individuals receiving buprenorphine for opioid use disorder (OUD). Associations between prescription stimulant use and treatment outcomes in this population have been understudied. Objectives:...
7.
Xu K, Mintz C, Presnall N, Bierut L, Grucza R
JAMA Netw Open
. 2022 May;
5(5):e2211363.
PMID: 35536575
Importance: Despite prevalent polysubstance use, treatment patterns and outcomes for individuals with opioid use disorder (OUD) and cooccurring substance use disorders (SUD) are understudied. Objective: To evaluate the distribution of...
8.
Parsley I, Dale A, Fisher S, Mintz C, Hartz S, Evanoff B, et al.
JAMA Netw Open
. 2022 Mar;
5(3):e222954.
PMID: 35297970
Importance: Alcohol use disorder (AUD) is common and associated with increased morbidity. The degree to which AUD currently factors into workplace absenteeism needs further characterization in the US. Objective: To...
9.
Xu K, Mintz C, Borodovsky J, Glaser P, Bierut L, Grucza R
Prim Care Companion CNS Disord
. 2021 Aug;
23(4).
PMID: 34352941
No abstract available.
10.
Mintz C, Presnall N, Xu K, Hartz S, Sahrmann J, Bierut L, et al.
Drug Alcohol Depend
. 2021 Jul;
226:108886.
PMID: 34245997
Background And Aims: Persons with opioid use disorder (OUD) and co-occurring alcohol use disorder (AUD) are understudied. We identified whether co-occurring AUD was associated with OUD treatment type, compared associations...